CPT 90480: SARS–CoV–2 Vaccine, First or Only Component
CPT code 90480 denotes the intramuscular administration of the first or sole component of a SARS–CoV–2 (COVID–19) vaccine. As a primary billing element for initial vaccine encounters, this code is central to documenting and reimbursing COVID‑19 immunization events across outpatient and ambulatory care settings. Nationally, accurate use of this code supports public health reporting, vaccine uptake monitoring, and consistent payment for vaccine administration services.
Key payers in the scope of this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for intramuscular COVID‑19 vaccine administration, typical sites of service where CPT code 90480 is used, and common billing practices associated with initial-dose vaccine administration. The publication also covers benchmarks and policy updates relevant to billing and coverage for COVID‑19 vaccine administration, as well as operational considerations for documenting the first or only vaccine component. Information absent from the input—such as detailed payer-specific coverage rules, associated taxonomies, and ICD‑10 diagnosis pairings—is noted as not available in the input.
Sign up for cpt 90480 policy alerts
Get alerted when payer policies referencing 90480 are released or updated.
Billing Code Overview
CPT code 90480 describes the administration of the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. This procedure represents a single vaccine administration event when the vaccine regimen requires one dose or when documenting the initial dose in a multi-dose series.
-
Service type: Vaccine administration by intramuscular injection
-
Typical site of service: Outpatient clinics, physician offices, public health vaccination sites, pharmacy-based clinics, and other ambulatory care settings
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to a primary care clinic during a seasonal vaccination drive requesting protection against SARS–CoV–2. The patient is screened for contraindications and vaccine history, consents to immunization, and is assigned to a medical assistant or nurse for administration. The provider documents vaccine manufacturer, lot number, expiration date, route (intramuscular), anatomical site (typically deltoid), and the VIS version and date in the medical record. The encounter includes verification of eligibility, counseling on common side effects, observation time as indicated, and electronic or paper reporting to the state immunization registry. Billing uses 90480 for the first or only administered COVID-19 vaccine component; vaccine product and administration supplies are reported separately when required by payer policies. Typical sites of service are outpatient primary care offices, community vaccination clinics, pharmacies (when clinic-based providers administer), and federally qualified health centers. A realistic workflow: patient check-in → screening and consent → vaccine preparation → administration using 90480 → post-vaccination observation and documentation → billing and immunization reporting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard reporting | Use when no additional modifier is required and service is billed under usual circumstances. |
25 | Significant, separately identifiable evaluation and management service | Use when a same-day E/M visit is performed and documented separately from the vaccine administration. |
59 | Distinct procedural service | Use when another procedure on a separate anatomical site or session is performed and appropriately documented. |
GT | Data transmission via interactive audio and video (Note: GT not listed in input; excluded) | Data not available in the input. |
GA | Automatic or advanced beneficiary notice on file | Use when the provider has a signed ABN for a service not expected to be covered. |
GQ | Via asynchronous telecommunications system (Note: GQ not listed in input; excluded) | Data not available in the input. |
RT | Right side | Use when laterality documentation is required for the injection site (right deltoid). |
LT | Left side | Use when laterality documentation is required for the injection site (left deltoid). |
AQ | Clinical trial vaccine not otherwise specified | Use when vaccination is provided under a qualifying clinical trial and payer requires this indicator. |
AS | Patient is enrolled in qualifying clinical research study | Use when the vaccine administration is part of a clinical study and the study requires this modifier. |
XE | Separate encounter | Use when the vaccine administration occurs during a separate, unrelated encounter. |
XP | Separate practitioner | Use when a different practitioner from the E/M service performs the administration. |
XS | Separate structure | Use when the vaccine is administered to a different anatomical site or distinct structure. |
XU | Unusual non-overlapping service | Use to indicate a service that is distinct because it does not overlap typical work with another billed service. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207Q00000X | Family Medicine | Primary care physicians who routinely provide adult and geriatric immunizations. |
208D00000X | General Practice | Providers in general practice settings who administer vaccines. |
208000000X | Internal Medicine | Internists who provide preventive services including COVID-19 vaccination. |
363LP0808X | Nurse Practitioner | Nurse practitioners authorized to administer vaccines in clinic settings. |
367500000X | Physician Assistant | Physician assistants who commonly deliver immunization services in outpatient care. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
Z23 | Encounter for immunization | Primary diagnosis code used when administering a vaccination such as with 90480. |
Z20.828 | Contact with and (suspected) exposure to other viral communicable diseases | Used when documenting exposure risk prompting immunization discussion or for public health tracking. |
Z00.129 | Encounter for routine child health examination without abnormal findings | Applicable when vaccination occurs during a routine preventive visit (if patient pediatric age ranges apply to vaccine formulation). |
Z00.00 | Encounter for general adult medical examination without abnormal findings | Applicable for adult preventive visits where vaccination is administered. |
Z71.89 | Other specified counseling | Used when counseling regarding vaccine risks, benefits, or side effects is a documented part of the encounter. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
90471 | Immunization administration (single vaccine) by intramuscular, subcutaneous, or intradermal injection; first dose | Alternate vaccine administration code used when billing non-COVID vaccines or when payer requires standard immunization administration codes instead of vaccine-specific codes. |
90472 | Each additional vaccine component, intramuscular/subcutaneous/intradermal (List separately in addition to code for primary vaccine) | Used when multiple vaccine components are administered in the same visit (e.g., multi-component COVID-19 series billed alongside 90480 for first component). |
90658 | Influenza virus vaccine, quadrivalent, split virus, preservative free, for intramuscular use | Example of a vaccine product code that may be administered during the same visit; product codes for vaccine doses are reported in addition to administration codes according to payer policy. |
0011A | COVID-19 vaccine, mRNA, spike protein, preservative-free, 30 mcg/0.3 mL dose, 1st dose | Product-specific vaccine code (example) that represents the vaccine drug; reported separately from 90480 when required for inventory and reimbursement. |
99070 | Supplies and materials (e.g., bandages, gauze), used during patient care, not included with the procedure | Used to report expendable supplies when payer allows separate supply reimbursement in addition to the vaccine administration code. |